← Evidence map

TrialNPJ primary care respiratory medicine2017

Comprehensive assessment of the safety of olodaterol 5 µg in the Respimat

Andrea Koch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2017
2018
2019
2020
2021
2022
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 29061968